United States · FDA National Drug Code directory
CARBAMAZEPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-731_a2eb2307-49f2-44de-9398-7a4783a26851
- Product NDC
- 62332-731
- Form
- TABLET
- Composition / generic term
- CARBAMAZEPINE
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241231
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (62332-731-10) / 10 TABLET in 1 BLISTER PACK · 62332-731-10
- 100 TABLET in 1 BOTTLE (62332-731-31) · 62332-731-31
- 60 TABLET in 1 BOTTLE (62332-731-60) · 62332-731-60
- 1000 TABLET in 1 BOTTLE (62332-731-91) · 62332-731-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →